Diuretics decrease fluid balance in patients on invasive mechanical ventilation: the randomized-controlled single blind, IRIHS study.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
10 03 2021
Historique:
received: 28 09 2020
accepted: 16 02 2021
entrez: 11 3 2021
pubmed: 12 3 2021
medline: 7 9 2021
Statut: epublish

Résumé

Fluid overload has been associated with increased morbidity and mortality in critically ill patients. The goal of this study was to assess the efficacy and safety of a diuretic strategy to overcome positive fluid balance in patients on invasive mechanical ventilation. Design: Multicenter, single-blind, randomized-controlled study. Patients were randomized into a diuretic (furosemide) or a control group. Patients were eligible in case of fluid overload defined as in-ICU weight increase ≥ 3%, invasive mechanical ventilation (FiO 171 patients were randomized. After 5 exclusions, 166 patients were included in the analysis: 77 in the diuretic and 89 in the control group. Fluid balance was 1.4 [- 2.5 to 4.5] kg in the diuretic and 6.4 [0.5-11.2] kg in the control group (p < 0.001). In the multiple imputation analysis, fluid balance was significantly decreased in the diuretic group (mean difference = - 4.8 95% CI [- 7.3 to - 2.5], p < 0.001). Eleven (14%) patients died in the diuretic group and 16 (18%) patients in the control group (p = 0.5). There was a worsening of Acute Kidney Injury in 67 (75.3%) patients of the control group versus 46 (59.7%) patients in the diuretic group (p = 0.03). In this multicenter randomized-controlled study, protocolized diuretic therapy reduced fluid accumulation in patients receiving mechanical ventilation and was well tolerated with a favorable safety profile. Trial registration NCT02345681, Registered January 26 2015, Prospectively registered, https://clinicaltrials.gov/ct2/show/NCT02345681?term=02345681&draw=2&rank=1 .

Sections du résumé

BACKGROUND
Fluid overload has been associated with increased morbidity and mortality in critically ill patients. The goal of this study was to assess the efficacy and safety of a diuretic strategy to overcome positive fluid balance in patients on invasive mechanical ventilation.
METHODS
Design: Multicenter, single-blind, randomized-controlled study. Patients were randomized into a diuretic (furosemide) or a control group. Patients were eligible in case of fluid overload defined as in-ICU weight increase ≥ 3%, invasive mechanical ventilation (FiO
RESULTS
171 patients were randomized. After 5 exclusions, 166 patients were included in the analysis: 77 in the diuretic and 89 in the control group. Fluid balance was 1.4 [- 2.5 to 4.5] kg in the diuretic and 6.4 [0.5-11.2] kg in the control group (p < 0.001). In the multiple imputation analysis, fluid balance was significantly decreased in the diuretic group (mean difference = - 4.8 95% CI [- 7.3 to - 2.5], p < 0.001). Eleven (14%) patients died in the diuretic group and 16 (18%) patients in the control group (p = 0.5). There was a worsening of Acute Kidney Injury in 67 (75.3%) patients of the control group versus 46 (59.7%) patients in the diuretic group (p = 0.03).
CONCLUSIONS
In this multicenter randomized-controlled study, protocolized diuretic therapy reduced fluid accumulation in patients receiving mechanical ventilation and was well tolerated with a favorable safety profile. Trial registration NCT02345681, Registered January 26 2015, Prospectively registered, https://clinicaltrials.gov/ct2/show/NCT02345681?term=02345681&draw=2&rank=1 .

Identifiants

pubmed: 33691730
doi: 10.1186/s13054-021-03509-5
pii: 10.1186/s13054-021-03509-5
pmc: PMC7943707
doi:

Substances chimiques

Diuretics 0
Furosemide 7LXU5N7ZO5

Banques de données

ClinicalTrials.gov
['NCT02345681']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

98

Références

Am J Respir Crit Care Med. 2017 Apr 15;195(8):1022-1032
pubmed: 27653798
Crit Care. 2015 Apr 02;19:135
pubmed: 25879573
Intensive Care Med. 2015 Sep;41(9):1620-8
pubmed: 26109396
Crit Care Med. 2016 May;44(5):981-91
pubmed: 26741579
Anesthesiology. 2011 Sep;115(3):541-7
pubmed: 21792056
JAMA. 2012 Nov 21;308(19):1985-92
pubmed: 23180503
Am J Respir Crit Care Med. 2012 Dec 15;186(12):1256-63
pubmed: 22997204
Acta Anaesthesiol Scand. 2018 Aug;62(7):936-944
pubmed: 29664109
Crit Care Med. 2018 Mar;46(3):425-429
pubmed: 29227369
Intensive Care Med. 2005 Apr;31(4):517-23
pubmed: 15754196
Crit Care. 2020 Mar 4;24(1):75
pubmed: 32131879
Crit Care Med. 2009 Oct;37(10 Suppl):S309-15
pubmed: 20046115
N Engl J Med. 2006 Jun 15;354(24):2564-75
pubmed: 16714767
Eur Respir J. 2007 May;29(5):1033-56
pubmed: 17470624
JAMA. 2002 Nov 27;288(20):2547-53
pubmed: 12444861
Clin Nutr. 2006 Apr;25(2):210-23
pubmed: 16697087
Crit Care Med. 2006 Jun;34(6):1691-9
pubmed: 16625136
Crit Care Med. 2012 Jun;40(6):1753-60
pubmed: 22610181
Crit Care. 2015 Jun 15;19:251
pubmed: 26073560
Anesthesiology. 2008 Oct;109(4):723-40
pubmed: 18813052
Intensive Care Med. 2005 Dec;31(12):1643-7
pubmed: 16193330
Intensive Care Med. 2016 Nov;42(11):1695-1705
pubmed: 27686349
Intensive Care Med. 2011 Jul;37(7):1166-73
pubmed: 21533569
Crit Care Med. 2011 Feb;39(2):259-65
pubmed: 20975548
Crit Care Med. 2018 Oct;46(10):1600-1607
pubmed: 29985214
Crit Care Med. 2013 Jun;41(6):1543-54
pubmed: 23528802
Ann Surg. 2007 Apr;245(4):622-8
pubmed: 17414612
N Engl J Med. 2012 Jul 12;367(2):124-34
pubmed: 22738085
Crit Care. 2020 Feb 28;24(1):70
pubmed: 32111247

Auteurs

Raphaël Cinotti (R)

CHU Nantes, Pôle Anesthésie-Réanimation, Service d'Anesthésie Réanimation Chirurgicale, Hôpital Guillaume et René Laennec, Université de Nantes, 44800, Saint-Herblain, France.

Jean-Baptiste Lascarrou (JB)

Médecine Intensive et Réanimation, Hôtel Dieu, University Hospital of Nantes, 1 place Alexis Ricordeau, 44093, Nantes, France.

Marie-Ange Azais (MA)

Médecine Intensive et Réanimation, Centre Hospitalier Départemental de la Vendée, La Roche-sur-Yon, France.

Gwenhaël Colin (G)

Médecine Intensive et Réanimation, Centre Hospitalier Départemental de la Vendée, La Roche-sur-Yon, France.

Jean-Pierre Quenot (JP)

Service de Médecine Intensive-Réanimation, CHU Dijon-Bourgogne, Dijon, France.
Equipe Lipness, Centre de Recherche INSERM UMR1231 et LabEx LipSTIC, Université de Bourgogne-Franche Comté, Dijon, France.
INSERM, CIC 1432, Module Épidémiologie Clinique, Université de Bourgogne-Franche Comté, Dijon, France.

Pierre-Joachim Mahé (PJ)

CHU Nantes, Pôle Anesthésie-Réanimation, Service d'Anesthésie Réanimation Chirurgicale, Hôtel Dieu, Université de Nantes, 44093, Nantes, France.

Antoine Roquilly (A)

CHU Nantes, Pôle Anesthésie-Réanimation, Service d'Anesthésie Réanimation Chirurgicale, Hôtel Dieu, Université de Nantes, 44093, Nantes, France.
Laboratoire UPRES EA 3826 «Thérapeutiques cliniques et expérimentales des infections», University Hospital of Nantes, 1 rue Gaston Veil, 44035, Nantes Cedex 1, France.

Aurélie Gaultier (A)

Direction de la recherche, Plateforme de Méthodologie et Biostatistique, CHU de Nantes, Nantes, France.

Karim Asehnoune (K)

CHU Nantes, Pôle Anesthésie-Réanimation, Service d'Anesthésie Réanimation Chirurgicale, Hôtel Dieu, Université de Nantes, 44093, Nantes, France. karim.asehnoune@chu-nantes.fr.
Laboratoire UPRES EA 3826 «Thérapeutiques cliniques et expérimentales des infections», University Hospital of Nantes, 1 rue Gaston Veil, 44035, Nantes Cedex 1, France. karim.asehnoune@chu-nantes.fr.

Jean Reignier (J)

Médecine Intensive et Réanimation, Hôtel Dieu, University Hospital of Nantes, 1 place Alexis Ricordeau, 44093, Nantes, France. jean.reignier@chu-nantes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH